Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 23 of Gain Therapeutics, Inc.'s SEC filings and found 7 warrant series, 2 ATM programs, 2 shelf registrations and 1 completed offering on file for GANX. The latest dilution event on file is ATM sales on Aug 7, 2026. Analysis updated Oct 7, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
KLRSKalaris Therapeutics Inc
ONCYOncolytics Biotech Inc.
ALPSALPS Group Inc Ordinary Share
HYFTMindWalk Holdings Corp.
HOWLWerewolf Therapeutics, Inc.
PLRXPliant Therapeutics, Inc.
IBIOiBio, Inc.
CNTBConnect Biopharma Holdings Limited
ELOXEloxx Pharmaceuticals, Inc.
CRBUCaribou Biosciences, Inc.
BMEABiomea Fusion, Inc.
OSTXOS Therapies Incorporated
ANVSAnnovis Bio, Inc.
MREOMereo BioPharma Group plc American Depositary Shares
HRTXHeron Therapeutics, Inc.